Currently getting a master’s in genomics at Oxford. My thesis is focused on optimizing probe design for bait capture sequencing for infectious disease diagnostics/surveillance. Worked on biosecurity research around far-UVC safety @SecureBio. Organized EA Munich for >2 years and did some EA community building in Germany. Studied 3 years of clinical medicine.
Sometimes, I write about meditation and other stuff. You can find my writing on my website or Substack: https://glozematrix.substack.com/
Feel free to reach out to me at my email address, and let me know if you’d like to chat: hello [at] maxgoerlitz [dot] com
(last updated in March 2024)
Thanks for your transparency and for updating this report; I think it is tremendously valuable. I have only skimmed so far, but I will hopefully read through it completely soon.
I also tried to do a back-of-the-envelope calculation of the cost-effectiveness of 254 nm upper-room GUV per eACH a while ago. I estimated higher numbers in my model, more on the order of $100/eACH/year (For context: the report estimates ~$14/eACH/year). Note that the model is pretty rough, but I’ll post it anyway in case it proves useful for others.
I think this difference comes mainly from having a much lower point estimate of eACH that is realistically achievable. In general, I am rather skeptical of eACH estimates for GUV that go into the hundreds.
As far as I understand, the way eACH are calculated depends on the specific pathogen in question. Pathogens vary widely in their susceptibility to GUV, and coronaviruses are unusually susceptible IIRC. Since many of these eACH estimates were calculated based on measurements with coronaviruses, this inflates the values, and they’d presumably be significantly lower for other pathogens.
Another point is that AFAICT, the higher eACH estimates mostly (all?) come from computational models and not real-world measurements. I assume that real-world environments are messy and will be less ideal for achieving very high eACH rates.
I think I had another reason for my skepticism, but unfortunately, I can’t recall it right now—will update this comment should I remember.